Tesamorelin (10mg – 20mg)

Tesamorelin (GHRH Analog)

Tesamorelin is a synthetic 44-amino-acid peptide analog of growth hormone-releasing hormone (GHRH), cataloged extensively as a potent molecular tool for investigating neuroendocrine regulation and metabolic pathways in controlled laboratory settings. Designed to stimulate growth hormone (GH) secretion with improved stability over endogenous GHRH, it offers researchers critical insights into adipose tissue metabolism, myogenic markers, and GH axis dynamics.

By providing a stabilized exogenous source of this peptide, Tesamorelin allows investigators to explore G-protein-coupled receptor signaling and IGF-1 mediation within preclinical models. Supplied as a stable, lyophilized powder by Protide Health, this formulation is optimized for researchers requiring standardized, high-purity tools for complex cellular and animal modeling in both 10mg and 20mg variable sizes.

Peptide Type: Growth Hormone-Releasing Hormone (GHRH) Analog
Vial Content: 10mg or 20mg Tesamorelin (trans-3-hexenoyl-GHRH 1-44-NH2)
Form: Lyophilized (Freeze-Dried) for maximum biochemical stability

Tesamorelin: Technical Overview & Research Properties

Tesamorelin is synthesized to investigate the core pathways of neuroendocrine signaling. Comprising the full 44-amino-acid sequence of human GHRH, this peptide features a unique N-terminal trans-3-hexenoyl modification. This structural enhancement is designed to protect the peptide from rapid enzymatic degradation, significantly extending its research-ready half-life in laboratory models.

Like all high-tier research compounds, Protide Health’s Tesamorelin is supplied in a vacuum-sealed, freeze-dried state to ensure molecular integrity during transit and storage, bypassing the instability often observed in unformulated liquid states.

Core Research Properties:

• Molecular Stability: The N-terminal trans-3-hexenoyl modification extends the peptide’s half-life for extended observational windows.

• Handling: Intended for precise laboratory reconstitution.

• Primary Models: Neuroendocrine regulation, adipose tissue metabolism, and skeletal muscle cell regeneration assays.

Mechanism of Action: GHRH Receptor Stimulation

Tesamorelin is observed functioning primarily by selectively activating GHRH receptors (GHRHR) in pituitary somatotrophs. It triggers GH release through a well-documented G-protein-coupled receptor signaling pathway.

Research Insight: In in vitro models, Tesamorelin binds to GHRHR, resulting in increased cyclic AMP (cAMP) and calcium levels. This mechanism leads to an observable increase in GH secretion in isolated pituitary cell cultures. This targeted GH release subsequently mediates hepatic insulin-like growth factor-1 (IGF-1) production, influencing both anabolic and lipolytic pathways without significantly elevating cortisol, prolactin, or ACTH levels.

Advanced Research Applications for Tesamorelin

1. Adipose Tissue Metabolism Models

Tesamorelin is heavily investigated for its effects on fat metabolism via GH and IGF-1 pathways. Preclinical rodent studies observe reductions in visceral fat mass following administration, a mechanism attributed to increased lipolysis via hormone-sensitive lipase (HSL) activation. Researchers also utilize the peptide to study enhanced β-oxidation and fatty acid utilization in isolated adipocytes.

2. Muscle Physiology and Anabolic Pathways

Tesamorelin’s GH-mediated effects are explored extensively in muscle physiology studies. Preclinical models investigate its role in upregulating myogenic markers (such as MyoD and myogenin) in skeletal muscle cells. Researchers track changes in lean mass and protein synthesis to understand the peptide’s role in cellular regeneration and anabolic signaling.

3. Neuroendocrine & GH Axis Dynamics

Tesamorelin serves as a primary model for studying GH axis dynamics. In laboratory settings, it is utilized to induce pulsatile GH secretion in animal models, closely mimicking physiological patterns. Researchers measure cAMP production in pituitary cell cultures to better understand GHRHR signaling and explore complex GH deficiency models.

Specifications Table: Tesamorelin

FAQs: Tesamorelin Peptide

What makes Tesamorelin different from standard GHRH?

Tesamorelin features an N-terminal trans-3-hexenoyl modification. In laboratory research, this structural change has been shown to protect the compound from rapid enzymatic cleavage, allowing researchers a wider window to observe GH and IGF-1 mediation in preclinical models.

Are there different sizes available for Tesamorelin research?

Yes. To accommodate varied experimental protocols and dosing models, Protide Health supplies Tesamorelin in both 10mg and 20mg lyophilized vials.

How is Tesamorelin stored for research stability?

In lab environments, it is stored as a lyophilized powder at -20°C. Reconstituted solutions should be handled according to institutional SOPs and kept refrigerated to minimize degradation of the peptide sequence.

Where can I buy Tesamorelin online?

Qualified researchers can purchase Tesamorelin 10mg and 20mg vials through Protide Health, where every batch is strictly third-party tested for >99% purity via HPLC verification.

Conclusion: Summary for Researchers

Tesamorelin, a synthetic GHRH analog, is a highly precise research tool for studying GH secretion, adipose tissue metabolism, and myogenic anabolism. By selectively activating GHRH receptors, it provides a multifaceted platform for exploring the intersection of neuroendocrine regulation and metabolic pathways. Available exclusively for laboratory use in 10mg and 20mg variants, this peptide is a vital asset for advancing preclinical endocrinology discovery.

Citations

Spoonko J et al., Tesamorelin pharmacology and clinical applications. PubMed Central.
Chen X et al., Tesamorelin pharmacokinetics and metabolic impact. PubMed Central.
Falciani F et al., Tesamorelin selectivity and neuroendocrine mechanisms. PubMed Central.
Koutkia P et al., Tesamorelin clinical trials and metabolic endpoints. PubMed Central.

Legal Disclaimer

Tesamorelin is intended for laboratory research purposes only. It is not approved by the FDA for human consumption, medical use, or self-administration outside of specific approved clinical indications. All research must be conducted by qualified professionals within a controlled environment. Researchers must comply with all applicable local, state, and federal regulations, including obtaining necessary approvals for experimental use. Products sold by Protide Health are for laboratory research purposes only and are not intended for human consumption, medical use, or veterinary use.